A short 2 week dose titration regimen reduces the severity of flu-like symptoms with initial interferon gamma-1b treatmentDEVANE, John G; MARTIN, Mary L; MATSON, Mark A et al.Current medical research and opinion. 2014, Vol 30, Num 6, pp 1179-1187, issn 0300-7995, 9 p.Article

Interferon gamma-1b : a review of its pharmacology and therapeutic potential in chronic granulomatous diseaseTODD, P. A; GOA, K. L.Drugs (Basel). 1992, Vol 43, Num 1, pp 111-122, issn 0012-6667Article

Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosisANTONIOU, K. M; NICHOLSON, A. G; DIMADI, M et al.The European respiratory journal. 2006, Vol 28, Num 3, pp 496-504, issn 0903-1936, 9 p.Article

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosisRAGHU, Ganesh; BROWN, Kevin K; BRADFORD, Williamson Z et al.The New England journal of medicine. 2004, Vol 350, Num 2, pp 125-133, issn 0028-4793, 9 p.Article

Interféron gamma-1b^(Imukin°) : Ostéopétrose maligne sévère: Trop d'inconnues = Interferon gamma-1b for severe malignant osteopetrosis : critical studyLa Revue Prescrire. 2006, Vol 26, Num 273, pp 414-414, issn 0247-7750, 1 p.Article

Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon γ-1b for the treatment of metastatic renal cell carcinomaELHILALI, M. M; GLEAVE, M; FRADET, Y et al.BJU international (Papier). 2000, Vol 86, Num 6, pp 613-618, issn 1464-4096Article